Minocycline for Chronic Autoimmune Uveitis
Conditions:   Minocycline;   Uveitis;   Retinal Degeneration Intervention:   Drug: minocycline Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2022 Category: Research Source Type: clinical trials

Minocycline Treatment for Cystoid Macular Edema
Conditions:   Minocycline;   Cystoid Macular Edema Intervention:   Drug: minocycline Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2022 Category: Research Source Type: clinical trials

Minocycline for Chronic Autoimmune Uveitis
Conditions:   Minocycline;   Uveitis;   Retinal Degeneration Intervention:   Drug: minocycline Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2022 Category: Research Source Type: clinical trials

Minocycline Treatment for Cystoid Macular Edema
Conditions:   Minocycline;   Cystoid Macular Edema Intervention:   Drug: minocycline Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2022 Category: Research Source Type: clinical trials

Minocycline for Chronic Autoimmune Uveitis
Conditions:   Minocycline;   Uveitis;   Retinal Degeneration Intervention:   Drug: minocycline Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2022 Category: Research Source Type: clinical trials

A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN ® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects
Condition:   Pharmacokinetics Interventions:   Drug: DFD-29 (Minocycline) Fasting;   Drug: DFD-29 (Minocycline) Fed;   Drug: Solodyn (Minocycline) Fasting Sponsors:   Journey Medical Corporation;   Dr. Reddy's Laboratories Limited Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2022 Category: Research Source Type: clinical trials

Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke
Condition:   Acute Ischemic Stroke Intervention:   Drug: Minocyclin Sponsor:   State University of New York at Buffalo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2022 Category: Research Source Type: clinical trials